• Multiple Myeloma — An Interview with Dr Surbhi Sidana on Optimizing the Role of CAR T-Cell Therapy

  • 2025/02/18
  • 再生時間: 28 分
  • ポッドキャスト

Multiple Myeloma — An Interview with Dr Surbhi Sidana on Optimizing the Role of CAR T-Cell Therapy

  • サマリー

  • Featuring a slide presentation and related discussion from Dr Surbhi Sidana, including the following topics:

    • Key clinical data of FDA-approved chimeric antigen receptor (CAR) T-cell therapies (0:00)
    • Real-world evidence evaluating utility of CAR T-cell therapies in the clinic (8:08)
    • Impact of prior BCMA-targeted treatment on CAR T-cell therapy efficacy (12:55)
    • Investigational CAR T-cell therapies in clinical development (15:08)
    • Incidence and management of toxicities associated with CAR T-cell therapy (18:21)

    CME information and select publications

    続きを読む 一部表示

あらすじ・解説

Featuring a slide presentation and related discussion from Dr Surbhi Sidana, including the following topics:

  • Key clinical data of FDA-approved chimeric antigen receptor (CAR) T-cell therapies (0:00)
  • Real-world evidence evaluating utility of CAR T-cell therapies in the clinic (8:08)
  • Impact of prior BCMA-targeted treatment on CAR T-cell therapy efficacy (12:55)
  • Investigational CAR T-cell therapies in clinical development (15:08)
  • Incidence and management of toxicities associated with CAR T-cell therapy (18:21)

CME information and select publications

activate_buybox_copy_target_t1

Multiple Myeloma — An Interview with Dr Surbhi Sidana on Optimizing the Role of CAR T-Cell Therapyに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。